Biocompatible Polymer-Coated Silver Prussian Blue Nanoparticles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biomedical applications of Prussian blue nanoparticles have not extensively explored their potential for cancer therapeutics and antibacterial activity, and there is a need for alternative anti-cancer and anti-bacterial agents that do not rely on external drugs or antibiotics.
Innovation Solution
Development of biocompatible polymer-coated silver Prussian blue nanoparticles (SPB-NPs) using poly(N-vinyl-2-pyrrolidone) as a stabilizing agent, which are highly stable and exhibit significant antibacterial and anticancer properties, including inhibition of cancer cell proliferation and tumor growth, while showing low toxicity to normal cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If Prussian blue nanoparticles are used for biomedical applications, then their chelating property and biocompatibility are utilized, but their potential for cancer therapeutics and antibacterial activity has not been extensively explored
Solution Approach 1:
The patent creates a composite material by coating Prussian blue nanoparticles with a biocompatible polymer shell, forming a core-shell structure. This composite approach enhances the versatility of PBNPs for cancer therapeutics and antibacterial applications while maintaining their inherent stability and chelating properties.
Solution Approach 2:
The biocompatible polymer acts as an intermediary layer between the Prussian blue nanoparticle core and the biological environment. This mediator enhances biocompatibility and stability while enabling new therapeutic functions for cancer and bacterial treatments.
2Adaptability or versatility
If metal nanoparticles are used for disease treatment, then their unique physical and chemical properties are utilized, but their stability in physiological conditions may be compromised
Solution Approach 1:
The patent develops a composite nanoparticle system where metal Prussian blue cores retain their unique physical and chemical properties for therapeutic functions, while the polymer coating provides enhanced stability in physiological conditions, resolving the contradiction between functionality and stability.
Solution Approach 2:
The biocompatible polymer forms a flexible protective shell around the metal nanoparticle core, maintaining the core's therapeutic properties while providing stability in physiological environments through the protective film.
3Reliability
If polymer coating is applied to Prussian blue nanoparticles, then biocompatibility is enhanced, but the complexity of synthesis increases
Solution Approach 1:
The patent employs preliminary action by using the polymer coating as both a stabilizing agent during synthesis and as a biocompatibility enhancer in the final product. The polymer is introduced at the synthesis stage to prevent aggregation and provide biocompatibility simultaneously, simplifying the overall process.
Solution Approach 2:
The polymer serves as an intermediary that facilitates both the synthesis process and the biocompatibility requirement, acting as a dual-function agent that reduces overall system complexity while achieving multiple objectives.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SPB-NPs demonstrate excellent antibacterial activity against both gram-negative and gram-positive bacteria and exhibit potent anticancer effects by inducing apoptosis in cancer cells, with potential for use as a low-cost alternative therapeutic agent.
Implementation Method 1
an improved method for the synthesis of poly(N-vinyl-2-pyrrolidone) (PVP)-stabilized silver hexacyanoferrate nanoparticles where polymer acts as stabilizing or capping agent
Implementation Method 2
exhibit potent anticancer effects by inducing apoptosis in cancer cells
Data Source
AI summary
The present invention relates to highly biocompatible or nontoxic PVP (poly(n-vinyl-2-pyrrolidone) coated silver prussian blue nanoparticles (SPB-NPS: Ag3[Fe(CN)6] where PVP acts as stabilizing or capping agent. The as-synthesized nanoparticles (SPB-NPs) have been thoroughly characterized by several analytical tools. The SPB-NPs are highly stable for more than two weeks towards different physiological buffers or solutions with different pH (pH=6, −7.4 &−8). These nanoparticles (SPB-NPs) exhibit biocompatibility towards various normal cells (HUVEC, CHO, & ECV304) but show significant inhibition of proliferation of different cancer cells in vitro and tumor growth in C57/BL6/J mice model (aggressive murine melanoma cancer model: B16F10). Additionally, the SPB-NPs show excellent antibacterial activity towards gram-negative (E. coli) and gram-positive (B. subtilis) bacteria. Consider all results together; these biocompatible SPB-NPs would be potentially useful for the development towards alternative anti-cancer agent as well as anti-bacterial agent in near future.